Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VITA2: Phenytoin Effect on Nevirapine PK and Resistance in PMTCT
NCT01187719Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- May 2010
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label trial of phenytoin in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Elimination half-life of nevirapine up to 2 weeks. Started May 2010; status: completed.
02
Drugs
phenytoin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01187719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01187719.